Document Detail


Calcium antagonists--adverse drug interactions.
MedLine Citation:
PMID:  2908714     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In the clinical management of heart disease, calcium channel blockers are generally prescribed in combination with one or more anti-angina, antiarrhythmic, or antihypertensive agents. Two different mechanisms are involved in drug interactions: pharmacokinetic and pharmacodynamic. In the former, the disposition of one drug is altered by the action of another, causing an increase or decrease in its absorption or its modified distribution, metabolism, or excretion. In pharmacodynamic interactions, the physiologic effects of one drug interfere either directly or indirectly with those of another, for instance, by alterations in fluid or electrolyte balance. This effect may be antagonistic or additive. The present work outlines the possible adverse interactions between the three main calcium antagonists and other therapeutic agents, including digoxin, beta blockers and antiarrhythmic, anesthetic, antihypertensive, antiasthmatic, and antidiabetic drugs and contrast media. Knowledge of these effects is of major clinical importance in the treatment of cardiac patients.
Authors:
H Reicher-Reiss; H N Neufeld; F X Ebner
Related Documents :
7831444 - Clinical investigation of monoamine neurotransmitter interactions.
8818854 - Drug interactions with azithromycin and the macrolides: an overview.
797504 - Drug interactions and clinical pharmacokinetics.
2286594 - Drug interactions with quinolones.
8174504 - Persistence of ethanol self-administration as a function of interreinforcer interval an...
12669964 - Effect of colonic lactulose availability on the timing of drug release onset in vivo fr...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  1     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  1987 Dec 
Date Detail:
Created Date:  1991-05-01     Completed Date:  1991-05-01     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  403-9     Citation Subset:  IM    
Affiliation:
Heart Institute, Tel Aviv University, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology
Animals
Anti-Arrhythmia Agents / pharmacokinetics,  pharmacology
Antihypertensive Agents / pharmacology
Calcium Channel Blockers / pharmacokinetics*
Digoxin / pharmacology
Drug Interactions
Humans
Male
Middle Aged
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Anti-Arrhythmia Agents; 0/Antihypertensive Agents; 0/Calcium Channel Blockers; 20830-75-5/Digoxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of calcium entry blockers on blood pressure and vasoconstrictor responses to alpha-1 adrenoce...
Next Document:  Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failu...